Healthcare provider profile · identity verified

Thomas Charles Dotson, M.D.P.C.

Internal Medicine · MANASSAS, VA · NPI 1659356079

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	813	232
Levothyroxine Sodium	Levothyroxine Sodium	452	114
Metformin Hcl	Metformin Hcl	389	111
Losartan Potassium	Losartan Potassium	349	102
Lisinopril	Lisinopril	348	102
Simvastatin	Simvastatin	334	95
Amlodipine Besylate	Amlodipine Besylate	288	86
Hydrochlorothiazide	Hydrochlorothiazide	227	67
Duloxetine Hcl	Duloxetine Hcl	209	65
Rosuvastatin Calcium	Rosuvastatin Calcium	197	68
Pantoprazole Sodium	Pantoprazole Sodium	189	62
Omeprazole	Omeprazole	183	60
Metoprolol Succinate	Metoprolol Succinate	171	52
Glimepiride	Glimepiride	161	45
Famotidine	Famotidine	153	57
Carvedilol	Carvedilol	146	47
Gabapentin	Gabapentin	145	48
Furosemide	Furosemide	144	55
Tamsulosin Hcl	Tamsulosin Hcl	141	43
Allopurinol	Allopurinol	130	36
Potassium Chloride	Potassium Chloride	130	51
Albuterol Sulfate Hfa	Albuterol Sulfate	122	46
Montelukast Sodium	Montelukast Sodium	113	36
Trazodone Hcl	Trazodone Hcl	110	32
Pravastatin Sodium	Pravastatin Sodium	109	33
Ozempic	Semaglutide	107	22
Metoprolol Tartrate	Metoprolol Tartrate	97	26
Zolpidem Tartrate	Zolpidem Tartrate	93	25
Sertraline Hcl	Sertraline Hcl	91	25
Ezetimibe	Ezetimibe	83	24
Clopidogrel	Clopidogrel Bisulfate	74	22
Azithromycin	Azithromycin	72	60
Cephalexin	Cephalexin	71	56
Atenolol	Atenolol	69	20
Eliquis	Apixaban	68	21
Januvia	Sitagliptin Phosphate	64	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	64	22
Fluticasone Propionate	Fluticasone Propionate	62	24
Alprazolam	Alprazolam	54	16
Prednisone	Prednisone	52	34
Tizanidine Hcl	Tizanidine Hcl	52	20
Colchicine	Colchicine	50	14
Mupirocin	Mupirocin	50	34
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	50	19
Lansoprazole	Lansoprazole	49	11
Alendronate Sodium	Alendronate Sodium	48	16
Tresiba Flextouch U-100	Insulin Degludec	48	13
Amoxicillin	Amoxicillin	47	39
Finasteride	Finasteride	47	16
Cefuroxime	Cefuroxime Axetil	44	35
Escitalopram Oxalate	Escitalopram Oxalate	44	15
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Folic Acid	Folic Acid	43	13
Synthroid	Levothyroxine Sodium	43	13
Valacyclovir	Valacyclovir Hcl	43	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	42	suppressed
Jardiance	Empagliflozin	41	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	11
Donepezil Hcl	Donepezil Hcl	37	11
Pregabalin	Pregabalin	37	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	27
Doxycycline Hyclate	Doxycycline Hyclate	36	27
Fenofibrate	Fenofibrate Nanocrystallized	36	12
Olmesartan Medoxomil	Olmesartan Medoxomil	36	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	35	23
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Tramadol Hcl	Tramadol Hcl	34	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	33	20
Ramipril	Ramipril	32	suppressed
Telmisartan	Telmisartan	32	suppressed
Fluconazole	Fluconazole	31	26
Ibuprofen	Ibuprofen	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Metformin Hcl Er	Metformin Hcl	31	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Irbesartan	Irbesartan	30	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Levofloxacin	Levofloxacin	28	22
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Morphine Sulfate Er	Morphine Sulfate	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	27	12
Rybelsus	Semaglutide	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Nystatin	Nystatin	26	13
Tradjenta	Linagliptin	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Clonazepam	Clonazepam	25	suppressed
Dutasteride	Dutasteride	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	15
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	20	15
Estradiol	Estradiol	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Farxiga	Dapagliflozin Propanediol	17	suppressed
Methylprednisolone	Methylprednisolone	17	17
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lidocaine	Lidocaine	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Celecoxib	Celecoxib	14	suppressed
Citalopram Hbr	Citalopram Hydrobromide	14	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Colesevelam Hcl	Colesevelam Hcl	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Valsartan	Valsartan	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	11
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Toprol Xl	Metoprolol Succinate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Testosterone	Testosterone	12	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Indomethacin	Indomethacin	11	suppressed
Linzess	Linaclotide	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error